Orthopedic Surgery Doctors in Flemington, NJ Accepting Medicare

12 Orthopedic Surgery doctors found. Showing 1 - 12

Dr. Philip Justin Glassner, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Sand Hill Rd, Suite 102, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Michael E Pollack, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Wescott Drive, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Robert Cameron More, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Wescott Drive, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

George Gorgy, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 8100 Wescott Dr, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Dr. Eric Michael Gordon, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Wescott Dr, Suite 101, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Michael Thomas Milone, MD Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Wescott Dr Ste 101, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Jerome Elliot Decker, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Wescott Drive, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Patrick Michael Collalto, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Wescott Drive, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Dr. Thomas A St John, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Wescott Drive, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Daniel Torino, M.D. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 8100 Wescott Dr Ste 101, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Richard Chang, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 Wescott Dr, Suite 101, Flemington, NJ 08822 Phone: 908-782-0600    Fax: 908-782-7575

Dr. Norman Glassner, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1100 Wescott Dr, Suite G2, Flemington, NJ 08822 Phone: 908-788-6457    Fax: 908-806-2529

News Archive

Inhibiting Notch signalling makes hormone-receptor positive cells dependent on estrogen

Within many hormone-receptor positive breast cancers lives a subpopulation of receptor-negative cells - knock down the hormone-receptor positive cells with anti-estrogen drugs and you may inadvertently promote tumor takeover by more dangerous, receptor-negative cells.

BioTime announces 21 new stem cell products for sale

BioTime, Inc. announced today that on August 1, 2010 the Company will be offering for sale 21 new stem cell products for research use only. These products will include the novel stem cell lines: E120 expressing the gene LGR5 useful in colon cancer drug discovery, EN16, T43, RAD20.5, RA-SKEL8, SM22, and Z1, full properties of which will be disclosed on product launch, along with differentiation kits and media for the culture of each line.

State highlights: Conn. bill would maintain coverage for low-income parents; Wis. may pay hospitals for uninsured care; Is hospital data sale a risk to patient privacy?

The House of Representatives adopted an omnibus bill Tuesday to implement numerous social service policy changes in the next state budget, including the end of a health coverage program launched by former Gov. M. Jodi Rell to help the uninsured. One thing it doesn't change: Medicaid eligibility for low-income parents. Gov. Dannel P. Malloy had proposed restricting eligibility for the program, a move that would have caused an estimated 37,500 parents to lose Medicaid coverage (Phaneuf and Becker, 6/4).

Parkinson's disease medication turns on critical gene, protects brain cells

In a major breakthrough in the battle against Parkinson's disease, researchers at the University of Colorado School of Medicine have discovered a drug that stops the progression of the degenerative illness in mice and is now being tested in humans.

IPC signs agreement with UCSF to develop leadership training program for physician managers

IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has entered into an agreement with the University of California, San Francisco Division of Hospital Medicine and its Center for the Health Professions to develop a leadership training program for dozens of IPC's key physician managers.

Read more Medical News

› Verified 9 days ago